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ABSTRACT 
Drugs bearing indole alkaloids are known to produce important pharmacological effects. Kopsia fruticosa 
(KF), member of thee Genus Kopsia containing four indole alkaloids possesses central nervous system (CNS) 
pharmacological effects. This study was conducted to explore the CNS effects of KF in rodents. 
Materials and Methods: The propylene glycolic solution (KF1) and aqueous solution (KF2) were prepared 
from the dried extract of the leaves of KF. Evaluation of hexobarbitone induced sleeping time in mice, 
analgesic effect by Tail flick response on thermal stimulus in rats, locomotor activity by Spontaneous motor 
activity and rotarod method in rats, sedative ataxic score by inclined plane method in mice and behavioural 
activity by Gross behavioural effects, Conditional Avoidance response, and cataleptic effects in rats were 
performed at 2, 4, 8,16 mg/kg of body weight respectively. 
Results: KF1 reduced the spontaneous locomotor activity and exploratory behaviour in mice (p<0.001-0.01) 
more than KF2. KF1 in all doses potentiated the hypnotic dose (p<0.001) of hexobarbitone and sub-hypnotic 
dose (upto 80% potentiation) of hexabarbitone as compared to only 40% potentiation by KF2. Anti-
nociception effect was found to be absent at all doses. KF1 possesses moderate sedative ataxic effect 
(p<0.001) and KF2 at 8mg/kg b.w. revealed mild effect (p<0.05) when compared to pentobarbitone. KF1 
induced a moderate degree of catalepsy and potentiated cataleptic and sub-cataleptic doses of haloperidol at 
all doses (p<0.001). 
Conclusion: The present study has revealed that the propylene glycolic extract of the leaves Kopsia fruticosa 
possesses profound action on the CNS thereby paving the way to further research. 
KEYWORDS: Kopsia fruticosa, hexobarbitone induced sleeping time, sedative atyaxic score, catalepsy.
INTRODUCTION 
 Drugs bearing indole alkaloids are known to 
produce important pharmacological effects. Genus Kopsia 
belonging to Apocynaceae family contained about 34 
species and most of the plants under this genus were 
reported to possess indole alkaloids. Kopsia fruticosa, 
member of this genus contains four indole alkaloids (Fig. 
1& 2) whose pharmacological effects have not been 
extensively studied. It has been reported that most of the 
indigenous plant having indole alkaloids exhibit varieties of 
pharmacological actions like hypotension, central nervous 
system depression, local anaesthesia, dilatation of both 
peripheral and coronary vessels and antileukemic effect 
etc.1 
 Hence it was conceived that the compounds of 
Kopsia fruticosa (KF) may produce some interesting 
pharmacological actions especially on the central nervous 
system. The crude extract was prepared from the dried 
leaves in laboratory and detailed pharmacological studies 
were carried out. The chief objective of this study was to 
evaluate the possible effects of KF on the central nervous 
system in laboratory animals. 
MATERIALS AND METHODS 
Test formulations and animals used for the study 
 The leaves of Kopsia fruticosa were provided by 
the Central Council for Research in Ayurvedic Sciences 
(CCRS), Kolkata, West Bengal. Solutions for the present 
study were prepared from the dried total extract of leaves 
of KF using the Soxhlet apparatus and the propylene 
glycolic solution of KF was designated as KF1 while the 
aqueous solution of KF designated as KF2. The animals 
used for this study were recruited from Indian Institute of 
Chemical Biology (IICB), Kolkata, West Bengal. 
Ethics Clearance 
 The present work was MD Thesis dissertation 
work of SM during 1992-94 at the department of 
Pharmacology of Institute of Post-Graduate Education and 
Research (IPGMER) and Seth Sukhlal Karnani Memorial 
Hospital (SSKM), Kolkata. At that time Institutional Animal 
Ethics Committee (IAEC) was not in vogue and the 
permission to initiate and continue this research work was 
granted by the guide Professor Dipankar Bhattacharyya, 
and head of the department of Pharmacology. 
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Effect on hexobarbitone induced sleeping time in mice 
 The sleep evaluation method was based on 
potentiation of hexobarbital-induced sleeping time.2 The 
animals were administered a single dose of the vehicle, 
diazepam, and the extracts by intraperitoneal (i.p.) route. 
Hexobarbitone Sodium (100 mg/kg, i.p.) was injected 30 
minutes after administration of the test drug and vehicle in 
all groups for screening of centrally acting compounds.2 
The time elapsed between loss and recovery of the righting 
reflex was noted and taken as sleeping time. This reflex 
was considered positive when the animal placed on its side 
recovers from this position within one minute. It was 
considered lost when the recovery requires longer period. 
This time has been expressed in minutes. Sleeping time 
was expressed as Mean ± SEM.  
 The compounds KF1 and KF2 were studied on 
hexobarbitone induced hypnosis in mice following the 
methods of Kopera and Armitage3 and UK Seth4 with some 
modifications. There were eight groups of six albino mice 
each. KF1 and KF2 were administered to six groups of 
animals in doses of 4 mg. 8 mg and 16 mg/kg body weight 
i.p. respectively. In all the groups of animals, drugs were 
administered 15 minutes before the administration of 
hexobarbitone sodium (100 mg/kg. body wt.) i.p. Next we 
tried the hypnotic prolongation effect of KF1 and KF2 and 
subhypnotic dose of hexobarbitone i.e. 50 mg/kg. body 
weight, i.p. The duration of sleep was taken to be the time 
between loss of righting reflex and the re-appearance of 
the same. The experiment was carried out at room 
temperature and the mean sleeping time of each of the 
control and the drug treated groups were recorded 
accordingly. 
Study on Analgesic effect - Tail flick response of rat on 
thermal stimulus 
 Rat tail flick response to thermal stimulus was 
utilized for the measurement of analgesic activity. The use 
of radiant heat as a thermal stimulus for the measurement 
of strong analgesics was employed by D’ Amour and Smith 
(1941)5, Guzral & Khanna (1957)6 using electrically heated 
nichrome wire. A “Techno analgesiometer “served this 
purpose and was employed for the analgesic tests of the 
compounds. Wistar Albino rats of either sex weighing 
between 150 to 250 gm were assigned to eight groups, 
each comprising of five animals were used for the test. One 
group of the rats served as control and was treated with 
normal saline 0.5 ml i.p. The other six groups were treated 
with KF1 and KF2 in doses of 4, 8 and 16 mg/kg body wt. 
i.p. 15 minutes before the administration of morphine 
respectively. Morphine (Ms), as a standard analgesic agent 
was used in another group at the dose of 10 mg/kg. i.p. and 
the potentiating effect of KF1 and KF2 on subanalgesic 
dose of morphine i.e. 2 mg/kg. body wt i.p. was then 
studied. At first a control study with rats treated with 
normal saline was made. Then rats treated with test drugs 
KF1, KF2 and morphine were put on analgesiometer at the 
rate of one animal at a time. The time taken to flick the tail 
in response to radiant heat was considered as the end 
point and taken as the withdrawal time 30 seconds was 
taken as the cut off time and the observations were noted 
and then tabulated. 
Studies on the locomotor activity  
Spontaneous motor activity  
 The method followed to determine the effect of 
KF1 and KF2 on spontaneous activity of mice (15 to 20 g. 
of body weight) was essentially that of Szymanski (1914)7 
with some modification. Light wiremesh cages measuring 
about 10 cm x 10 cm were suspended from a hook by a 
light rubber string. A thread was tied at the bottom of the 
cage while the other end was tied to a frontal lever 
through pulleys. Movements of the animal kept in cage 
resulted in oscillation of the cages which was recorded on 
a smoked slowly moving drum with the help of frontal 
writing lever. Three mice were kept one at a time in the 
three cages and their movements were recorded and the 
animals which were found to be docile were discarded. 
Three groups of mice containing five mice in each group 
were thus selected in doses of 2.5, 5 and 10 mg/kg body 
wt. of KF1 and KF2 respectively and the other group were 
treated with the drug KF2 in the same doses like KF1. 
Observation was made for 4 hours after the administration 
of drugs. Increase or diminution in the spontaneous motor 
activity in mice was adjusted by increase or diminution in 
the amplitude of recording on the smoked drum. 
Rota rod method with rats 
 The present study was carried out with rats 
weighing from 150 to 200 g were placed on a horizontal 
scrapped iron rod, having a diameter of 2 cm. and rotating 
at the rate of 10 revolutions per minute. Circular sections 
were used to divide the linear space of the rod in 6 lengths, 
so that 6 rats could be tested at a time and they did not 
interact with each other. The rod was placed at least 15 
inches above the table top to prevent the animals from 
spontaneously jumping off the rod8. Five groups of such 
animals, each group containing 5 rats were selected. The 
first group was injected intraperitoneally with normal 
saline (control), and 3rd group were injected i.p. with 
propylene glycol 0.5 ml. while the other two groups were 
injected i.p. with glycolic solution of K. fruticosa (total 
extract) in doses 2.5 and 5 mg/kg of body weight 
respectively. Each group was then placed on the rod after 
an interval of 30 minutes. An animal falling more than once 
to remain on the rod for 3 minutes the test was considered 
to be positive. The number of falls during the 3 minutes 
period were noted and the mean of the number of falls 
against each dose was calculated and tabulated. 
Evaluation of sedative ataxic score (inclined plane 
method with mice) 
 The inclined screen test is suitable to rapid and 
fairly accurate estimates of sedative activity and is simple 
to carry out 9. In this study the sedative ataxic score of K. 
fruticosa (KF1) were carried out by following the method 
of Bhargave and Gupta (1977)10. Seven groups of six mice 
screened beforehand were used for evaluation of the 
sedative ataxic effect of K. fruticosa were treated with 
hexobarbitone to compare the sedative ataxic effect of the 
plant extract with a standard hypnotic drug. Doses of the 
drug KF1, KF2 and hexobarbitone selected were 4 mg and 
8 mg/ kg body wt. respectively. One of group of mice was 
treated with normal saline 0.5 ml i.p. In all the cases drugs 
were injected i.p. 15 minutes before starting the 
 Int. J. Ayur. Pharma Research, 2016;4(6):1-8  
 IJAPR | June 2016 | Vol 4 | Issue 6   3 
experiment. Sedative ataxic score was then determined by 
following the method of Tislow (1966)11 and it was graded 
as slight (score of 1-2) moderate (score of 3-4) or marked 
(score of 5). The scores obtained by observing the activity 
of five animals in each group were determined and 
tabulated in Table - 1. 
Table 1: Detection of sedative ataxic score 
Score Toleration of side or back position Activity in vertical pole Activity on inclined pole 
0 No Grasps pole & walks down Moves actively on screen 
1 No Grasps pole & slide down Moves actively on screen 
2 No Grasps pole & slide down Cannot move at all only sluggishly 
3 No Cannot grasp pole Cannot move at all only sluggishly 
4 No Cannot grasp pole Cannot hold on to the screen 
Effects of the behavioural activity  
Gross behavioural effects  
 Mice in five groups of 6 animals in each were 
taken and the four groups were treated i.p. with KF1 and 
KF2 in doses of 4 mg/kg body wt and 8 mg/kg body wt 
respectively. The fifth group received 1 ml of NS i.p. The 
changes in the behavioural attitude was noted, if any, for a 
period of 2 hours in intervals of 30 minutes each. 
Conditional Avoidance response in rats  
 To study the effect of Kopsia fruticosa on 
conditional avoidance response, the technique of “ 
Jumping box “ as described by Warner (1932) with some 
modification by Piala et al., (1959)12 was used. Thirteen 
groups of rats containing 5 animals each were selected for 
the experiment. One group served as control and was 
treated with normal saline 0.5 ml i.p. the other twelve 
groups were divided into four broad groups so that each 
broad group contained three groups of 5 animals each. 
Those broad groups were treated with hexobarbitone, 
KF1, KF2, and chlorpromazine. KF1 and KF2 were given in 
doses of 2.5, 5 and 10 mg/kg body wt. respectively to each 
three groups of the four broad group of animals. Drugs 
were administered by i.p. route 15 minutes before start of 
the experiment. Response of the animals in response to 
buzzer and/or electro shock was observed. 
Cataleptic effects  
 In pilot studies, effects of 4 and 8 mg/kg body wt 
i.p. of KF were observed to induce cataleptic stances in 
some of the animals. So any cataleptic effect per sec of the 
extract was evaluated by the following method. Catalepsy 
was first qualitatively measured by the staging system and 
later quantified by the “ring test”. Four distinct stages are 
discernable which are attained gradually. 
Stage I - animals site quietly, without any attempt to move, 
unless pushed gently. 
Stage II - animals does not move on being pushed. 
Stage III -animal maintains an abnormal posture, in which 
its forepaws are gently placed on lower retort ring (7.5 cm 
high) for 30 seconds or more. 
Stage IV-animals maintains for 30 seconds or more, an 
abnormal posture, where one of its forepaws is lifted 
and/or one of the hind paws remained suspended in the 
air. 
 Once the animal attained stage IV or the deepest 
attainable stage, it was subjected to the “ring test” of 
Pertwee (1972)13, where the animals were placed gently 
on the upper ring (40 cm hitch) of the cataleptic stand” in a 
manner that the paws rested on the ring, their hand facing 
away from the vertical stand. The animal was closely 
observed for a total period of 5 minutes during which the 
animal remained perfectly immobile (the cessation of the 
stout and wiskering movements taken as index) with the 
exception of respiratory excursion and a typical sagging 
movement, was recorded to the nearest second with a stop 
watch. Another stop watch was used to mark the passage 
of total period of observation (5 minutes). The period of 
complete immobility gave the “immobility index” and was 
converted into “percentage immobility”.  
RESULTS 
1. Observation KF1, KF2 and hexobarbitone induced 
sleeping time in mice 
 Hexobarbitone or ultra short-acting barbiturate is 
a well known hypnotic suitable for experimentation 
because of its short duration of sedation. It was observed 
on intraperitoneal administration of KF1 and KF2 to study 
the effects on gross behaviour in albino mice, that the 
animals became very quiet and subdued for a considerable 
period of time. This observation led us to study the effects 
of the crude extract on hexobarbitone induced sleeping 
time in mice. The results are tabulated in Table 2 & 3 and 
as depicted in Figures 3 & 4. 
Table 2: Effects of KF1 and KF2 on hexobarbitone ( 100mg/kg b.w., i.p), (Hexo 100) induced sleeping time in mice 
(Each observation is an average of 5 animals ) 
Group Sleeping time Mean  S.E. p value 
Hexo 100 mg 30.0 0.62 - 
Hexo 100 mg + KF1 - 4mg 42.0  0.68 ( 0.001 ) 
Hexo 100 mg + KF1 - 8mg 46.0  0.80 ( 0.001 ) 
Hexo100 mg + KF1 - 16mg 52.0  0.84 ( 0.001 ) 
Hexo 100 mg + KF2 - 4mg 30.4  0.60 N.S* 
Hexo 100 mg + KF2 - 8mg 31.6  0.48 N.S* 
Hexo 100 mg + KF2 - 16mg  32.0  0.66   N.S* 
Note - N.S* denotes in comparison to control group, Student t-test. 
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 Figures 3  
 
Table 3: Observations on the effects of KF1 and KF2 on sub hypnotic (50 mg/kg. b.w., i.p) dose of hexobarbitone 
(Hexo 50)  
Group Hypnotic Potentiation Effect (%) 
Hexo 50 mg 00 
Hexo 50 mg + KF1 - 4mg 20 
Hexo 50 mg + KF1 - 8mg 40 
Hexo 50 mg + KF1 - 16mg 80 
Hexo 50 mg + KF2 - 4mg 00 
Hexo 50 mg + KF2 - 8mg 40 
Hexo 50 mg + KF2 - 16mg  40 
(Each observation is an average of 5 animals) 
Figures 4 
 
From the above tables it was observed, that KF1 in all doses i.e. 4, 8 and 16 mg/kg. b.w. i.p potentiated the hexobarbitone 
induced sleeping time in mice. However, KF2 failed to produce similar increase in sleeping time. 
2. Observations On The Analgesic Effect of KF1 AND KF2 
 Potentiation of sleeping time in mice by KF1 led us to undertake the present study, to observe whether KF1 and 
KF2 posses any analgesic effect or not. The drug extract was compared with sub-analgesic dose of 2 mg/kg. i.p) as 
standard anti-nonceptive agent. The results are tabulated in Table - 4. 
Table 4: The effect of KF1 and KF2 on sub analgesic dose of MS 
 Groups  Increase in latent period of tail flick 
response (in sec.) - Mean  S.E. 
 p value 
Morphine (MS) 1.46  0.32   - 
MS + KF1 (4 mg) 1.52  0.34  N.S* 
MS + KF1 (8 mg) 1.48  0.28    N.S* 
MS + KF1 (16 mg) 1.60  0.34   N.S* 
MS + KF2 (4 mg) 1.44  0.36   N.S* 
MS + KF2 (8 mg) 1.46  0.30  N.S* 
MS + KF2 (16mg) 1.54  0.34 N.S* 
- N.S* denotes in comparison to control group, Student t-test. 
(Each observation is an average of 5 animals) 
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KF1 and KF2 in all doses failed to produce no analgesic effect and also did not prolong the sub-analgesic dose of morphine. 
3. Observations On The Spontaneous Motility In Mice 
 To study the effect of KF1 and KF2 on the spontaneous motility in mice, the animals were kept in the “Jingling 
cage” and their normal movements were recorded. Then groups of animals containing 5 mice each, were injected 
intraperitoneally with KF1 and KF2 in doses of 2, 4, 8 and 16 mg/kg. b.w. respectively and the remaining group was 
treated with propylene glycol and served as control. In a dose of 2mg/kg. b.w. both KF1 and KF2 failed to produce any 
observable effect on the spontaneous motility of mice. Although doses 4 mg and 8 mg/kg.b.w. of KF1 markedly diminished 
the spontaneous movement and the exploratory movement of the mice was totally abolished. the mice in this group 
preferred to remain seated in the corners of the cages and this effect lasted almost 3 hours. In similar doses, KF2 however 
failed to produce any discornable effect on the spontaneous motility of the mice. 
 When 16mg/kg. b.w. of KF1 was administered there was complete cessation of movements of the mice and the 
effect lasted for almost 4 hours. The drug solution, KF2 in doses of 16 mg/kg. b.w., reduced the motility in mice, but the 
effect was rather short-lasting, lasting only 1 hour. 
4. Observations On The Rota Rod Test 
 It was observed that KF1 in doses of 2 mg/kg. b.w. did not significantly affect the motor activity of the mice. 
However, in higher dose i.e. 8 mg/kg. and 16 mg/kg. body weight, all the mice fell down more than twice, when the period 
of observation was kept fixed at 3 minutes. This observation was found to be statistically significant. This suggested that 
KF1 in 8 mg/kg. considerably affected the motor activity in mice, KF2, however, in doses of 2.8 mg did not significantly 
reduce the motor activity in mice. But in the dose of 16mg/kg. body wt. KF2, 3 out of 5 mice fell for twice in 3 minutes 
observation. The results are tabulated in Table - 5. 
Table 5: Observations on the effect of KF1 and KF2 on motor activity of mice as determined by Rota rod 
test Each group contain 5 albino rats ) 
Groups (Dosage in 
mg/kg b.w.) 
No. of falls by rats in each 
group during 3 minutes stay 
Mean  S.E. p value 
N. Saline (1 c.c.)  02 04  0.20  - 
KF1  
      2 
03 06  0.34 N.S* 
      8 12 2.4  0.36 (0.01) 
     16 16 3.2  0.42 (0.001) 
KF2 
      2 
02 04  0.24 N.S* 
      8 03  2.4  0.36 N.S* 
      16 06 1.2  0.38 N.S* 
Note -N.S* denotes in comparison to control group, Student t-test. 
5. Evaluation Of The Sedative Ataxic Score 
 The mean of the scores for each group of animals was calculated and tabulated in Table - 6 and reveals that the 
sedative ataxic score for control group of animals was zero. While, animals treated with drug KF1 in the doses of 4 mg/kg. 
and 8 mg/kg. body weight respectively, the score was 1.4 and 2.6 respectively. The drug solution KF2, which was 
administered in similar doses of 4.8 mg/kg. body wt. produced a score of 0.2 and 0.6 only. While pentobarbitone sodium in 
the doses of 4 and 8 mg./kg b.w. produced a score of 2.6 and 4.4 respectively.  
Table 6: Observation on the Sedative ataxic score in mice (Each group consists of five animals ) 
 Groups  Drug  Dose (mg/kg 
b.w. i.p) 
Sedative ataxic score  
Mean  S.E  
p value 
A NS 1 ml  0  - 
B KF1 4 1.4  0.24 <0.001 
C KF1 8 2.6  0.42 <0.001 
D KF2 4 0.2  0.12 N.S* 
E KF2 8 0.6  0.20 <0.05 
F Pentobarbitone 4 2.6  0.48 <0.001 
G Pentobarbitone 8 4.4  0.60 <0.001 
Note - N.S* denotes in comparison to control group by Student t-test. 
From the above table it can be observed that the sedative ataxic score was highest with pentobarbitone, moderate with 
drug solution KF1 and least with KF2. 
6. Observation On Behavioural Activities  
Gross Behavioural Activities 
 It was observed that KF1 in doses of 2.4/mg/kg. b.w. produced considerable CNS depression within 30 minutes of 
administration. The mice stopped all exploratory movements wiskering was diminished and totally stopped grooming 
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itself. The mice also developed ataxic movement and its gait was flattened and these effects lasted the whole period of 
observation. At similar doses KF2 however, produced only slight diminution of exploratory movements in mice, but it 
reduced wiskering and grooming habits of the animal and produce minimal ataxia. These effects lasted for more than 1 
hour only. In the dose of 8 mg/kg. b.w. of KF1, the animals became deeply sedated when observed at 30 minutes interval 
after administration. The righting reflex was preserved but the mice attained some abnormal postures, while these effects 
lasted over 3hours. While KF2 in a similar dose of 8 mg/kg. b.w. dose produced diminution of exploratory movement and 
the wiskering and grooming habits of the animals were stopped and also its gait was flattened. The animals however, did 
not lose the righting reflex or develop abnormal postures. In the control group of mice, which was treated with normal 
saline 1 ml. intraperitoneally, did not alter the normal gross behavioural activities of the mice. 
Conditioned Avoidance Response In Rats 
 The drug KF1 had previously shown a quietening and hypnotic effect in rats and mice. Therefore, it was felt 
necessary to further study this hypnotic effect and hence the evaluation of the conditioned avoidance response using the 
“jumping box” technique was undertaken. The drug KF1 and KF2 were compared with known sedatives/tranquillizers e.g. 
chlorpromazine and pentobarbitone, Piala et al., (1959)12 first used the “jumping box” technique and this method was 
followed here. A peculiar phenomenon was noticed whereby excessively trained rats who were showing “secondary 
response” i.e. jumping to the other side of the box, even on just putting the rat in the jumping box, before even the buzzer 
was sounded. This effect is blocked by anti-anxiety drugs like benzodiazepines. KF1 in higher doses i.e. 16 mg/kg. body wt. 
and above blocked this secondary response in rats. Both the drug solution KF1 and KF2 failed to produce any effect on the 
conditioned avoidance response in rats.  
Catalepsy Test 
 To quantify the catalepsy, as observed when K.fruticosa was administered in dose of 4 and 8 mg/kg. body wt. 
during pilot studies, the “ring test” of Pertwee (1972)13 was performed, and the results are tabulated in Table - 7.  
 Cataleptic (5.0 mg/kg. body wt. i.p) and subcataleptic (0.3 mg/kg. body wt.) doses of haloperidol were choosen. 
Haloperidol in 5 mg/kg. body wt dose induced moderate catalepsy in all treated animals, most of the attained at least stage 
III, KF1 in doses of 2 and 4 mg/kg. b.w. significantly potentiated, but in doses of 8 and 16 mg. b.w. effected maximum 
potentiation as all animals attaining Stage IV, while KF2 did not potentiate cataleptic dose of haloperidol. 
 Further 0.3 mg/kg. body wt. of haloperiodol i.p. does not induce significant catalepsy in most mice, with only few 
animals attaining Stage II. KF1 was given in dose of 2, 4, 8 and 16 (mg/kg. body wt. i.p.) along with sub cataleptic dose of 
haloperidol. The animals attaining mostly stage III, where 2 out of 5 animals in the group with 16 mg dose of KF1 attained 
stage IV, but KF2 did not potentiate sub cataleptic dose of haloperidol at all. The observations are tabulated in Table - 7 
Table -7: Effect of KF1 and KF2 on cataleptic and sub-cataleptic doses of haloperidol 
( Each observation is an average of 5 rats ) 
Drug with dose (in mg/kg b.w.) Cataleptic score P Value 
Halo 63.4  2.44 - 
Halo + KF1 (2) 82.4  1.26 <0.001* 
Halo + KF1 (4) 89.4  2.86 <0.001* 
Halo + KF1 (8) 89.8  2.28 <0.001* 
Halo + KF1 (16) 94.6  1.82 <0.001* 
Halo + KF2 (2) 63.8  2.42 N.S* 
Halo + KF2 (4) 64.2  2.44 N.S* 
Halo + KF2 (8) 65.2  2.38 N.S* 
Halo + KF2 (16) 65.4  2.42 N.S* 
HaloS 25.3  2.86 - 
HaloS + KF1 (2) 42.6  3.24 <0.001+ 
HaloS + KF1 (4) 48.4  4.26 <0.001+ 
HaloS + KF1 (8) 74.8  4.66 <0.001+ 
HaloS + KF1 (16) 76.4  4.68 <0.001+ 
HaloS + KF2 (2) 24.6  2.32 N.S* 
HaloS + KF2 (4) 26.6  3.42 N.S* 
HaloS + KF2 (8) 44.2  3.56 N.S* 
HaloS + KF2 (16) 62.2  3.58 N.S* 
(Halo=Cataleptic dose of haloperidol - 5 mg/kg. b.w. i.p.) 
(HaloS = Sub-cataleptic dose of haloperidol - 0.3 mg/kg. b.w. i.p.) 
‘*’ Statistical significance in comparison to ‘Halo’ group 
‘+’ Statistical significance in comparison to ‘HaloS’ group 
N.S* = Not significant, Student t-test. 
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DISCUSSION 
 The plant being investigated, i.e. Kopsia fruticosa 
(KF), in our studies have been reported to yield four 
different alkaloids, isolated from different parts of the 
plant. But all of them have indole moiety as basic nucleus. 
In the field of studies of indigenous plants, several potent 
pharmacological actions have been attributed to the 
presence of the indole alkaloids in the extracts of the 
plants. Though reports about pharmacological actions of 
KF are scanty, till now they have been reported to induce 
cholinergic actions14. Paucity in the previous literature 
regarding KF alkaloids prompted us to investigate the 
effects of the extracts of this plant on cardiovascular 
system, respiratory system, central nervous system as also 
effects on skeletal and smooth muscle preparations, as 
other members of Apocynaceae family have been reported 
to induce varieties of pharmacological effects like 
depression of the CNS and CVS, vasodilatory, local 
anaesthetic and others1. As this plant is not a native of 
even Indian subcontinent, being found mostly in Malaysian 
peninsula. Enormous and continuous supply of the plant is 
not there, so we concentrated on the effects of the total 
extract of leaves of KF.  
 Two different vehicles were used for preparing 
the extracts of the leaves of KF, namely, propylene glycolic 
solution of the extract designated as KF1 and aqueous 
solution of the extract designated as KF2, were made. 
Evaluating the effect of KF1 and KF2 on spontaneous 
locomotor activity in mice it was seen that both the 
extracts had a dampening effect on the locomotor 
movements of mice as seen by testing them in the “Jingling 
cage”. Effect wise KF2 was quite less effective than KF1. 
Both the spontaneous movements as well as exploratory 
behaviour were diminished. Mice treated with the extract 
were mostly cornered huddling together at the corners of 
the animal cage, with higher doses, this effect persisted for 
at least 4 hours after administration of the extract, 
showing a central nervous system depressant action. In 
rotating rod test at lower doses, there was not much effect 
but in higher doses, that is 8 mg/kg. body wt. dose of KF1 
and to fall of the tested rats, which fell down more than 
twice during the period of observation. KF2 was not much 
effective in this parameter. On evaluation of the sedative 
ataxic scores of KF1 and KF2 on mice and comparing them 
with the same effect of pentobarbitone, it was seen that 
KF1 had a moderate sedative ataxic effect, though not at 
par with pentobarbitone, KF2, in all doses was least 
effective. 
 In our study with rats about the effect of KF1 and 
KF2 on the conditioned avoidance response induced in the 
animals by the ‘jumping box’ method. Though the extract, 
showed calming effect but they did not modify the 
response in trained rats showing conditioned avoidance 
response. One peculiarity, a phenomenon was seen 
whereby excessively trained rats who were showing 
“secondary response” i.e. jumping to the other side of the 
box, even on just putting the rat in the jumping box, before 
even the buzzer was sounded. This is a response which is 
blocked by anti-anxiety drugs like benzodiazepines, KF1 in 
higher doses show a similar effect of blocking the 
‘secondary response’ without affecting the conditional 
avoidance response. 
 Observations of the effects of KF1 and KF2 on 
hexobarbitone induced sleeping time in mice, it was seen 
KF1 in all doses potentiated the hypnotic dose of 
hexobarbitone as well as the sub-hypnotic dose of 
hexabarbitone, also the subhypnotic dose of hexobarbitone 
could not induce sleep in any of the animals while there 
was dose dependent increase in the percentage of 
induction of sleep with KF1. KF2 was totally ineffective in 
modifying the response of both hypnotic as well as sub-
hypnotic dose of hexobarbitone. 
 Testing the drugs on the analgesiometer for their 
anti-nociceptive effect if any, both the solutions of the 
extracts were found to be devoid of any anti-nociceptive 
effect per se. Moreover, they could not potentiate sub-
hypnotic dose of morphine. 
 Observing the effects of KF1 and KF2 on the gross 
behavioural activities of mice, it was found that with KF1, 
the mice showed considerable central nervous system 
depression. The animals stopped all exploratory 
movements, wiskering was diminished and they stopped 
grooming themselves completely. The mice also developed 
ataxic movements and even attained abnormal postures. 
At similar doses, however, KF2 produced marginal 
decrease in motility of the mice with reduced wiskering 
and grooming, but no abnormal posture or ataxia was 
observed. 
 KF1 per se induced a moderate degree of 
catalepsy in the rats and also potentiated cataleptic and 
subcataleptic doses of haloperidol. Whereas KF2 could not 
potentiate haloperidol in its cataleptogenic action. It is too 
early, to conclude about the exact mode of action of the 
extract of KF, but seeing the ineffectiveness, of the two 
vehicles of the extract i.e. propylene glycol and distilled 
water in affecting in any way the different parameters as 
discussed above, on which the animals were tested, it can 
be postulated that KF1 has an central nervous system 
depressant, sedative, ataxic, cataleptic but not affecting the 
conditioned avoidance response (like minor tranquillisers) 
actions. KF2 was almost devoid of any effect on these CNS 
paradigms. Both KF1 and KF2 however, showed 
depressant effect as per haemodynamic and cardiac effects 
are concerned. It is very surprising, that the aqueous 
extract shows minimal CNS effects as compared to the 
glycolic extract, KF1. The reason cannot be explained at 
this stage and requires a further exploration and insight 
into their pharmacological properties. 
CONCLUSION 
 Both the solutions viz. propylene glycolic (KF1) 
aqueous (KF2) and extracts obtained from the leaves of 
Kopsia fruticosa have been studied in the present study. 
KF2 had dampening effect on the locomotor system. The 
spontaneous movements were diminished and there was a 
distinct calming effect. KF1 showed considerable CNS 
depressant effect which persisted for almost 4 hours. KF2 
or the aqueous solution of the crude extract produced 
minimal effect in these parameters. KF1 potentiated the 
hexobarbitone induced sleeping time in mice and even 
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potentiated the subhypnotic dose of hexobarbitone. But 
KF2 had no sedative effect and did not potentiate the 
hexobarbitone induced sleeping time in mice. Both the 
extracts, KF1 and KF2 had no analgesic effect. They also 
did not alter the conditional avoidance response in mice. 
However, KF1 produced a moderate degree of catalepsy 
and potentiated even the sub cataleptic dose of 
haloperidol. Hence, the present study with Kopsia fruticosa 
shows some interesting pharmacological effects with KF1, 
the propylene glycolic solution of the crude extract that 
possess CNS depressant, sedative, ataxic, cataleptogenic 
actions. While the aqueous solution of the crude extract 
had very little action on CNS paradigms. 
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